Inventor
HE HAIYING
CN65 patents
⚠️ This page may combine multiple inventors who share the name “HE HAIYING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD
6 patentsUS10875888B2Dec 29, 2020
Steroid derivative FXR agonist
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD3 citations71
US11667667B2Jun 6, 2023
Steroid derivative FXR agonist
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations60
US11434212B2Sep 6, 2022
Bicyclic compound as a caspase inhibitor
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations60
US10981860B2Apr 20, 2021
Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereof
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD1 citations59
US11891398B2Feb 6, 2024
2,3-dihydro-1H-pyrrolizine-7-formamide derivative and application thereof
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations51
US11059853B2Jul 13, 2021
Crystalline or amorphous form of steroid derivative FXR agonist, preparation method therefor and use thereof
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations50
ZHUHAI UNITED LABORATORIES CO LTD
5 patentsUS11932617B2Mar 19, 2024
Compound for use in retinal diseases
ZHUHAI UNITED LABORATORIES CO LTD3 citations74
US12473258B2Nov 18, 2025
Crystal form of pyridinylphenyl compound and preparation method therefor
ZHUHAI UNITED LABORATORIES CO LTD0 citations62
US11753377B2Sep 12, 2023
Crystal form of 2-methyl-2-propanol and amino-substituted aryl compound
ZHUHAI UNITED LABORATORIES CO LTD1 citations59
US12479823B2Nov 25, 2025
Compound for use in retinal diseases
ZHUHAI UNITED LABORATORIES CO LTD0 citations51
US12595259B2Apr 7, 2026
Aminopyridine compound
ZHUHAI UNITED LABORATORIES CO LTD0 citations50
SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD
5 patentsUS10100047B2Oct 16, 2018
Piperidine derivatives as orexin receptor antagonist
SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD5 citations72
US10912775B2Feb 9, 2021
Crystal form of orexin receptor antagonist compound, and preparation method and application thereof
SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD0 citations61
US10898486B2Jan 26, 2021
Crystal form of orexin receptor antagonist compound, and preparation method and application thereof
SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD0 citations61
US10874674B2Dec 29, 2020
Crystal form of orexin receptor antagonist compound, and preparation method and application thereof
SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD0 citations50
US10668066B2Jun 2, 2020
Crystal form of orexin receptor antagonist compound, and preparation method and application thereof
SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD0 citations50
SHANDONG DANHONG PHARMACEUTICAL CO LTD
4 patentsUS11001563B2May 11, 2021
SSAO inhibitor
SHANDONG DANHONG PHARMACEUTICAL CO LTD3 citations71
US12077513B2Sep 3, 2024
Process route of compound of formula (IV), crystal form and preparation method therefor
SHANDONG DANHONG PHARMACEUTICAL CO LTD0 citations60
US11505532B2Nov 22, 2022
SSAO inhibitor
SHANDONG DANHONG PHARMACEUTICAL CO LTD1 citations60
US10858322B2Dec 8, 2020
Process for preparing 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[D]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-one
SHANDONG DANHONG PHARMACEUTICAL CO LTD0 citations50
MEDSHINE DISCOVERY INC
3 patentsUS10647710B2May 12, 2020
Thiazole derivative and applications thereof
MEDSHINE DISCOVERY INC1 citations61
US12351587B2Jul 8, 2025
Bicyclic compound as RIP-1 kinase inhibitor and application thereof
MEDSHINE DISCOVERY INC0 citations52
US11680070B2Jun 20, 2023
Thieno[2,3-c]pyridazin-4(1H)-one derivative and application thereof
MEDSHINE DISCOVERY INC0 citations51
QILU PHARMACEUTICAL CO LTD
2 patentsCSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD
2 patentsUS11339147B2May 24, 2022
Lactam compound as FXR receptor agonist
CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD2 citations73
US12215098B2Feb 4, 2025
Solid form, crystalline form, and crystal form a of FXR agonist, and preparation method and application thereof
CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD0 citations62
GUANGDONG RAYNOVENT BIOTECH CO LTD
2 patentsJANSSEN BIOPHARMA INC
2 patentsFUJIAN AKEYLINK BIOTECHNOLOGY CO LTD
2 patentsGUANGZHOU OCUSUN OPHTHALMIC BIOTECHNOLOGY CO LTD
2 patentsUS11149055B2Oct 19, 2021
Crystal form of lanosterol prodrug compound and application thereof
GUANGZHOU OCUSUN OPHTHALMIC BIOTECHNOLOGY CO LTD0 citations59
US12329763B2Jun 17, 2025
Composition of lanosterol prodrug compound, preparation method therefor and use thereof
GUANGZHOU OCUSUN OPHTHALMIC BIOTECHNOLOGY CO LTD0 citations58
ZHANGZHOU PIEN TZE HUANG PHARM
2 patentsUS11673899B2Jun 13, 2023
Crystal form of thieno[2,3-c]pyridazine-4(1H)-one compound, preparation method therefor and use thereof
ZHANGZHOU PIEN TZE HUANG PHARM0 citations58
US11578081B1Feb 14, 2023
Crystal form as inhibitor of ACC1 and ACC2, and preparation method therefor and use thereof
ZHANGZHOU PIEN TZE HUANG PHARM0 citations57
Heilongjiang zhenbaodao pharmaceutical co ltd
2 patentsALIOS BIOPHARMA INC
1 patentJIANGSU KANION PHARMACEUTICAL CO LTD
1 patentFUJIAN COSUNTER PHARMACEUTICAL CO LTD
1 patentZHONGSHAN OPHTHALMIC CENTER SUN YAT-SEN UNIV
1 patentPHAENO THERAPEUTICS CO LTD
1 patentBREAKTHROUGH PHARMACEUTICALS INC
1 patentJIANGSU KANION PARMACEUTICAL CO LTD
1 patentUNIV FOSHAN
1 patentHUIZHOU TCL MOBILE COMMUNICATION CO LTD
1 patentCONJUSTAR ZHUHAI BIOLOGICS CO LTD
1 patentCISEN PHARMACEUTICAL CO LTD
1 patentShowing the top 50 of 65 patents by PatentIndex Score.